Sarepta Therapeutics is a pioneering biotechnology company dedicated to improving the lives of individuals with rare, genetic-based diseases. By focusing on precision genetic medicine, the company has successfully transitioned from a research-focused organization to a commercial-stage powerhouse, with a robust portfolio of approved therapies and a deep pipeline of gene therapy candidates for Duchenne muscular dystrophy and other muscle, central nervous system, and cardiac conditions.
At the heart of Sarepta is a mission-driven culture that values collaboration, innovation, and empathy. The company understands that scientific breakthroughs require a sustainable, supportive workplace, which is why they prioritize work-life integration and offer a comprehensive benefits package designed to support the holistic wellbeing of every employee.